---
title: "以岭药业的子公司获得中国批准生产阿尔茨海默病药物的原材料"
description: "以岭药业子公司获得中国对阿尔茨海默病药物原料的批准"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/265661137.md"
published_at: "2025-11-13T07:35:39.000Z"
---

# 以岭药业的子公司获得中国批准生产阿尔茨海默病药物的原材料

> 以岭药业子公司获得中国对阿尔茨海默病药物原料的批准

### Related Stocks

- [002603.CN - 以岭药业](https://longbridge.com/zh-CN/quote/002603.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules | Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules | [Link](https://longbridge.com/zh-CN/news/267815314.md) |
| Cipla incorporates subsidiary Cipla Middle East Company in Kingdom of Saudi Arabia | Cipla incorporates subsidiary Cipla Middle East Company in Kingdom of Saudi Arabia | [Link](https://longbridge.com/zh-CN/news/277484983.md) |
| Vedanta Named Preferred Bidder for Key Bauxite Block in Odisha | Vedanta Limited has been named the preferred bidder for the Karnapodikonda bauxite block in Odisha after a competitive e | [Link](https://longbridge.com/zh-CN/news/277228297.md) |
| SDI's Stock Pops as China's Sinocera Plans to Buy Australian Dental Materials Firm for USD110 Million | Shares of SDI surged over 45% to AUD1.28 after announcing its acquisition by China's Sinocera for AUD166 million (USD109 | [Link](https://longbridge.com/zh-CN/news/277428719.md) |
| Iran says Natanz nuclear site hit in US-Israeli strikes | VIENNA, March 2 (Reuters) - Iran’s sprawling nuclear facility at Natanz was struck during U.S. and Israeli military oper | [Link](https://longbridge.com/zh-CN/news/277439412.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。